Anhui Anke Biotechnology (Group) Co., Ltd.
SZSE:300009.SZ
10.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,865.752 | 2,331.063 | 2,168.765 | 1,701.417 | 1,712.53 | 1,461.55 | 1,096.268 | 849.216 | 635.755 | 542.406 | 430.346 | 337.94 | 267.917 | 227.93 | 190.644 | 156.49 | 125.874 | 127.77 |
Cost of Revenue
| 664.624 | 503.375 | 432.415 | 361.08 | 376.213 | 291.167 | 244.242 | 219.209 | 181.22 | 157.291 | 117.059 | 91.991 | 78.612 | 64.602 | 53.012 | 45.528 | 37.583 | 45.51 |
Gross Profit
| 2,201.128 | 1,827.688 | 1,736.35 | 1,340.337 | 1,336.316 | 1,170.383 | 852.026 | 630.007 | 454.535 | 385.115 | 313.287 | 245.949 | 189.304 | 163.328 | 137.632 | 110.962 | 88.291 | 82.259 |
Gross Profit Ratio
| 0.768 | 0.784 | 0.801 | 0.788 | 0.78 | 0.801 | 0.777 | 0.742 | 0.715 | 0.71 | 0.728 | 0.728 | 0.707 | 0.717 | 0.722 | 0.709 | 0.701 | 0.644 |
Reseach & Development Expenses
| 254.68 | 166.012 | 166.539 | 128.761 | 120.091 | 87.319 | 70.169 | 51.776 | 35.868 | 29.413 | 25.699 | 23.449 | 22.42 | 9.975 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 67.286 | 33.261 | 29.313 | 27.268 | 24.099 | 23.381 | 19.378 | 22.457 | 14.566 | 11.854 | 7.684 | 8.198 | 9.351 | 8.25 | 25.052 | 18.873 | 15.888 | 19.84 |
Selling & Marketing Expenses
| 472.39 | 734.352 | 812.435 | 679.536 | 701.272 | 640.619 | 371.29 | 268.173 | 218.502 | 190.305 | 155.39 | 120.655 | 88.606 | 78.086 | 63.312 | 49.586 | 41.358 | 39.962 |
SG&A
| 1,021.191 | 767.612 | 841.748 | 706.804 | 725.371 | 664 | 390.669 | 290.63 | 233.068 | 202.159 | 163.074 | 128.853 | 97.957 | 86.337 | 88.364 | 68.46 | 57.245 | 59.801 |
Other Expenses
| -5.81 | 81.972 | 98.64 | 53.985 | 83.448 | -1.033 | 0.192 | 12.277 | 7.758 | 4.041 | 4.993 | 10.266 | 5.159 | 10.825 | 5.531 | 1.679 | 1.715 | 1.593 |
Operating Expenses
| 1,321.429 | 1,015.596 | 1,106.927 | 889.55 | 928.91 | 825.688 | 529.026 | 410.873 | 305.854 | 263.817 | 216.015 | 175.454 | 143.596 | 113.666 | 90.652 | 70.186 | 58.586 | 60.88 |
Operating Income
| 923.979 | 841.994 | 660.064 | 424.042 | 401.777 | 310.629 | 329.052 | 219.307 | 150.14 | 122.672 | 101.048 | 75.642 | 69.256 | 50.273 | 45.75 | 40.46 | 26.247 | 15.591 |
Operating Income Ratio
| 0.322 | 0.361 | 0.304 | 0.249 | 0.235 | 0.213 | 0.3 | 0.258 | 0.236 | 0.226 | 0.235 | 0.224 | 0.259 | 0.221 | 0.24 | 0.259 | 0.209 | 0.122 |
Total Other Income Expenses Net
| -4.05 | -8.146 | -2.321 | -7.903 | -1.74 | -1.033 | 0.192 | 12.217 | 5.833 | 4.041 | 4.831 | 10.248 | 28.931 | 10.637 | 5.498 | 1.679 | 1.702 | 1.593 |
Income Before Tax
| 919.93 | 833.848 | 295.117 | 416.139 | 163.414 | 309.596 | 329.244 | 231.232 | 155.973 | 126.712 | 105.878 | 85.89 | 73.719 | 60.91 | 51.249 | 42.139 | 27.95 | 17.185 |
Income Before Tax Ratio
| 0.321 | 0.358 | 0.136 | 0.245 | 0.095 | 0.212 | 0.3 | 0.272 | 0.245 | 0.234 | 0.246 | 0.254 | 0.275 | 0.267 | 0.269 | 0.269 | 0.222 | 0.134 |
Income Tax Expense
| 61.341 | 96.129 | 91.731 | 69.604 | 53.016 | 44.844 | 47.461 | 33.359 | 23.542 | 17.941 | 16.008 | 11.945 | 11.338 | 9.273 | 6.678 | 6.075 | 6.453 | 2.343 |
Net Income
| 847.229 | 703.26 | 206.629 | 358.955 | 124.466 | 263.172 | 277.743 | 197.303 | 136.255 | 109.851 | 89.87 | 73.945 | 63.323 | 51.984 | 44.57 | 34.553 | 22.714 | 15.727 |
Net Income Ratio
| 0.296 | 0.302 | 0.095 | 0.211 | 0.073 | 0.18 | 0.253 | 0.232 | 0.214 | 0.203 | 0.209 | 0.219 | 0.236 | 0.228 | 0.234 | 0.221 | 0.18 | 0.123 |
EPS
| 0.52 | 0.43 | 0.13 | 0.22 | 0.076 | 0.17 | 0.18 | 0.13 | 0.095 | 0.079 | 0.065 | 0.054 | 0.047 | 0.048 | 0.04 | 0.035 | 0.024 | 0.016 |
EPS Diluted
| 0.52 | 0.43 | 0.13 | 0.22 | 0.076 | 0.17 | 0.18 | 0.13 | 0.095 | 0.079 | 0.065 | 0.054 | 0.047 | 0.048 | 0.04 | 0.035 | 0.024 | 0.016 |
EBITDA
| 1,022.914 | 921.944 | 403.491 | 483.19 | 249.434 | 366.118 | 392.884 | 283.617 | 184.594 | 151.261 | 122.007 | 99.568 | 88.895 | 73.568 | 61.396 | 49.665 | 38.781 | 31.457 |
EBITDA Ratio
| 0.357 | 0.4 | 0.342 | 0.306 | 0.271 | 0.273 | 0.355 | 0.333 | 0.294 | 0.285 | 0.286 | 0.297 | 0.337 | 0.329 | 0.324 | 0.318 | 0.306 | 0.265 |